Clinical Trial Update: High-Dose Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating high-dose chemotherapy followed by peripheral stem cell transplantation for hematologic cancers has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia
• Lymphoma
• Multiple Myeloma
• Myelodysplastic Myeloproliferative Neoplasms
• Myelodysplastic Syndromes

Snippet

Sponsor: Case Comprehensive Cancer Center | Conditions: Leukemia, Lymphoma | Phase 2 | Status: COMPLETED